News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zura Bio Limited - Class A Ordinary shares
(NQ:
ZURA
)
3.650
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
655
Open
3.650
Bid (Size)
3.520 (5)
Ask (Size)
3.720 (3)
Prev. Close
3.650
Today's Range
3.650 - 3.650
52wk Range
2.000 - 7.400
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
June 14, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology
June 06, 2024
From
Zura Bio Limited
Via
Business Wire
Performance
YTD
-16.09%
-16.09%
1 Month
-3.18%
-3.18%
3 Month
+31.29%
+31.29%
6 Month
-7.36%
-7.36%
1 Year
-44.02%
-44.02%
More News
Read More
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
June 03, 2024
From
Zura Bio Limited
Via
Business Wire
ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024
May 09, 2024
Via
InvestorPlace
Zura Bio Announces Participation in June Investor Conferences
May 29, 2024
From
Zura Bio Limited
Via
Business Wire
3 Penny Stocks to Buy Now: May 2024
May 24, 2024
Via
InvestorPlace
Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024
From
Zura Bio Limited
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
April 26, 2024
Via
Benzinga
Where Zura Bio Stands With Analysts
August 15, 2023
Via
Benzinga
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
April 18, 2024
From
Zura Bio
Via
Business Wire
Zura Bio Announces Robert Lisicki as CEO and Director
April 08, 2024
From
Zura Bio Limited
Via
Business Wire
ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023
March 28, 2024
Via
InvestorPlace
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
March 28, 2024
From
Zura Bio Limited
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
March 22, 2024
Via
Benzinga
Zura Bio Announces Participation at March Conferences
March 04, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Announces Participation at February Investor Conferences
February 02, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO
January 08, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
January 03, 2024
From
Zura Bio Limited
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
December 18, 2023
Via
Benzinga
Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok
December 04, 2023
From
Zura Bio Limited
Via
Business Wire
Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors
November 14, 2023
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 13, 2023
From
Zura Bio Limited
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
October 10, 2023
Via
Benzinga
Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute
September 12, 2023
From
Zura Bio Limited
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023
August 25, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close